AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics (including Botox).

$311.4B

Market Cap • 12/6/2024

2012

(12 years)
Founded

2012

(12 years ago)
IPO

NYSE

Listing Exchange
Flag of US

North Chicago

Headquarters • Illinois

S&P500 Participant

Index Composite • 2024

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions
  • ...and much more!

    Get Premium